ArticleUnited European gastroenterology journal2018
Mucosal healing and the risk of serious infections in patients with celiac disease.
Article in United European gastroenterology journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.
- A Call for Research on the Prognostic Role of Follow-Up Histology in Celiac Disease: A Systematic Review.Frontiers in physiology · 2019Pooled it
- Beyond gluten-free diet: Novel therapeutic frontiers in celiac disease armamentarium.World journal of gastrointestinal pharmacology and therapeutics · 2026Review
- Clinical and Histopathological Profile of Adults with Celiac Disease at Diagnosis and on a Gluten-Free Diet: A Cross-Sectional Observational Study.Clinics and practice · 2026Article
- Inflammation in cancer: therapeutic opportunities from new insights.Molecular cancer · 2025Review
- Increased Risk of Herpes Zoster Infection in Patients with Celiac Disease 50 Years Old and Older.Digestive diseases and sciences · 2024Article
- Article
- COVID-19 and celiac disease: a review.Therapeutic advances in gastroenterology · 2023Review
- Pigmented Corn Varieties as Functional Ingredients for Gluten-Free Products.Foods (Basel, Switzerland) · 2021Article
- How to manage celiac disease and gluten-free diet during the COVID-19 era: proposals from a tertiary referral center in a high-incidence scenario.BMC gastroenterology · 2020Review
- Defective spleen function in autoimmune gastrointestinal disorders.Internal and emergency medicine · 2020Article
- Hematologic Manifestations in Celiac Disease-A Practical Review.Medicina (Kaunas, Lithuania) · 2019Review
- Pigment Epithelium-Derived Factor Affects Angiogenesis in Celiac Disease.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2019Article
- Outcomes of SARS-CoV-2 infection in patients with celiac disease: a multicenter research network study.Annals of gastroenterologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 4 institutions in 4 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPatients with celiac disease (CD) are at increased risk of certain infections, but it is unknown if mucosal healing influences this risk.
methodsWe collected data on 29,096 individuals with CD (equal to villous atrophy) through Sweden's 28 pathology departments undergoing biopsy 1969-2008. Through the Swedish Patient Register we obtained information on any infection and specifically sepsis, streptococcal infection, influenza,
resultsOf 5598 CD individuals with no record of any infections before follow-up biopsy, 45% had persistent villous atrophy, 619 (24%) of them had a later infection, compared to 579 (19%) in those with mucosal healing (
conclusionsIn CD, mucosal healing does not influence the risk of serious infection requiring hospital-based medical attention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.